The price of shortening anti–hepatitis C virus therapy: Is this truly cost saving?
Zobair M. Younossi – 9 December 2015
Noncirrhotic portal hypertension: Medical and endoscopic management
S. K. Sarin, Cyriac Abby Philips, Rajeev Khanna – 9 December 2015
The Ethics of living related liver transplantation when deceased donation is not an option
Thomas D. Schiano, Rosamond Rhodes – 9 December 2015
Ethics and informed consent in patients with hepatocellular carcinoma: Changing roles for hepatologist and radiologist
Dirk J. van Leeuwen, Otto M. van Delden – 9 December 2015
Is it ethical to enroll a patient in a hepatitis C virus clinical trial when current standard of care is highly effective and safe?
Vijaya L. Rao, Christopher Daugherty – 9 December 2015
Genotype 3: Treat now or wait for something better?
Paul J. Pockros – 9 December 2015
Macrophage recruitment by fibrocystin‐defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis
Luigi Locatelli, Massimiliano Cadamuro, Carlo Spirlì, Romina Fiorotto, Silvia Lecchi, Carola Maria Morell, Yury Popov, Roberto Scirpo, Maria De Matteis, Mariangela Amenduni, Andrea Pietrobattista, Giuliano Torre, Detlef Schuppan, Luca Fabris, Mario Strazzabosco – 8 December 2015 – Congenital hepatic fibrosis (CHF) is a disease of the biliary epithelium characterized by bile duct changes resembling ductal plate malformations and by progressive peribiliary fibrosis, in the absence of overt necroinflammation.
Association between systemic inflammatory response syndrome and mortality in alcoholic hepatitis: A meta‐analysis
Veeravich Jaruvongvanich, Sikarin Upala, Anawin Sanguankeo – 8 December 2015
Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus‐Infected U.S. Women
Mark H. Kuniholm, Edgar Ong, Boris M. Hogema, Marco Koppelman, Kathryn Anastos, Marion G. Peters, Eric C. Seaberg, Yue Chen, Kenrad E. Nelson, Jeffrey M. Linnen – 8 December 2015 – Exposure to hepatitis E virus (HEV) is common in the United States, but there are few data on prevalence of HEV/human immunodeficiency virus (HIV) coinfection in U.S. populations. We tested 2,919 plasma samples collected from HIV‐infected (HIV+) women and men enrolled in U.S. cohort studies for HEV viremia using a high‐throughput nucleic acid testing (NAT) platform.